Intro -- Title Page -- Psyllium: the Path to Health and Happiness - a True Story of Transformation -- Introduction -- The dark times -- The discovery of psyllium -- The beginning of change -- The positive effects on digestion -- A new chapter of well-being -- The return to normality -- The passion for psyllium -- The dissemination of knowledge -- A sustainable change -- Conclusion -- Psyllium: the Natural Source for Health and Well-Being -- Introduction -- Chapter 1: the Health Benefits of Psyllium -- 1.1 Promotion of healthy digestion -- 1.2 Relief from constipation -- 1.3 Support for intestinal health -- 1.4 Reduction of gastrointestinal complaints -- Chapter 2: Weight Management with Psyllium -- 2.1 Appetite-suppressing properties of psyllium seeds -- 2.2 Support for weight reduction -- 2.3 Psyllium as part of a balanced diet -- Chapter 3: Cardiovascular Health and Psyllium -- 3.1 Lowering the cholesterol level -- 3.2 Blood pressure regulation and protection against heart disease -- 3.3 Anti-inflammatory effect of psyllium -- Chapter 4: Diabetes Management with Psyllium -- 4.1 Effects of psyllium on blood glucose levels -- 4.2 Improvement of insulin resistance -- 4.3 Psyllium as a support for diabetes control -- Chapter 5: Psyllium for Healthy Intestinal Flora -- 5.1 Prebiotic properties of psyllium seeds -- 5.2 Promoting the growth of good intestinal bacteria -- 5.3 Effects on the immune system and general health -- Chapter 6: Detoxification and Cleansing of the Body with Psyllium -- 6.1 The ability of psyllium to bind and eliminate toxins -- 6.2 Reduction of pollutants in the body -- 6.3 Psyllium as a natural detox method -- Chapter 7: Skin Health and Psyllium -- 7.1 Effects of psyllium on the skin -- 7.2 Alleviation of skin problems such as acne and eczema. -- 7.3 Beauty benefits of psyllium for healthy skin and hair.
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
"Love Across Borders takes readers through contentious frontiers around the world to reveal the widespread prejudicial laws intent on dividing us. Anna Lekas Miller tells her own gripping story of meeting Salem Rizk in Istanbul, where they were reporting on the Syrian civil war. But when Turkey started cracking down on refugees, Salem, who is Syrian, wasn't allowed to stay there, nor could he safely return to Syria. In this look at the global immigration crisis, Lekas Miller interweaves love stories similar to her own with a study of the history of passports, the legacy of colonialism, and the discriminatory laws shaping how people move through the world every day"--
Was uns Menschen eigentlich glücklich macht, ist in den letzten Jahren zu kurz gekommen: Fokus, Energie, Kreativität, Nähe und echte Verbundenheit. Zeit, uns das alles zurückzuholen! Dieses Buch ist für alle, die zu einer digitalen Achtsamkeit finden möchten, die mehr Raum lässt für das, was wirklich zählt. Anna Miller hilft mit konkreten Tipps und Übungen sich des eigenen Umgangs mit Smartphone und Bildschirmzeit bewusst zu werden und gleichzeitig eine neue Vision für ein gutes Leben zu entwickeln. Dafür verbindet sie wissenschaftliche Erkenntnisse aus der Positiven Psychologie, Neuropsychologie, Motivations- und Beziehungsforschung. Damit wir wieder mit den wichtigen Dingen in Verbindung treten ...
The creation and subsequent downsizing of Bears Ears National Monument has been one of the most publicized and politicized land management decisions within the state over the past decade. However, relatively little research has been conducted to determine if, and to what extent, the creation of the monument impacted outdoor recreation and recreation-related industries. Now, more than three years after the monument was created, there are sufficient data to take a retrospective look at the influence of the monument. The purpose of this research is to evaluate the influence of Bears Ears National Monument on outdoor recreation and its related industries in San Juan County, Utah.
In 2011, North Carolina (NC) created a program to facilitate Medicaid enrollment for state prisoners experiencing community inpatient hospitalization during their incarceration. The program, which has been described as a model for prison systems nationwide, has saved the NC prison system approximately $10 million annually in hospitalization costs and has potential to increase prisoners' access to Medicaid benefits as they return to their communities. This study aims to describe the history of NC's Prison-Based Medicaid Enrollment Assistance Program (PBMEAP), its structure and processes, and program personnel's perspectives on the challenges and facilitators of program implementation. We conducted semi-structured interviews and a focus group with PBMEAP personnel including two administrative leaders, two "Medicaid Facilitators," and ten social workers. Seven major findings emerged: 1) state legislation was required to bring the program into existence; 2) the legislation was prompted by projected cost savings; 3) program development required close collaboration between the prison system and state Medicaid office; 4) technology and data sharing played key roles in identifying inmates who previously qualified for Medicaid and would likely qualify if hospitalized; 5) a small number of new staff were sufficient to make the program scalable; 6) inmates generally cooperated in filling out Medicaid applications, and their cooperation was encouraged when social workers explained possible benefits of receiving Medicaid after release; and 7) the most prominent program challenges centered around interaction with county Departments of Social Services, which were responsible for processing applications. Our findings could be instructive to both Medicaid non-expansion and expansion states that have either implemented similar programs or are considering implementing prison Medicaid enrollment programs in the future.
In: Bulletin of the World Health Organization: the international journal of public health = Bulletin de l'Organisation Mondiale de la Santé, Band 85, Heft 11, S. 843-850
Due to recent involvement in military conflicts, and an increase in the use of explosives, there has been an escalation in the incidence of blast-induced traumatic brain injury (bTBI) among US military personnel. Having a better understanding of the cellular and molecular cascade of events in bTBI is prerequisite for the development of an effective therapy that currently is unavailable. The present study utilized organotypic hippocampal slice cultures (OHCs) exposed to blast overpressures of 150 kPa (low) and 280 kPa (high) as an in vitro bTBI model. Using this model, we further characterized the cellular effects of the blast injury. Blast-evoked cell death was visualized by a propidium iodide (PI) uptake assay as early as 2 h post-injury. Quantification of PI staining in the cornu Ammonis 1 and 3 (CA1 and CA3) and the dentate gyrus regions of the hippocampus at 2, 24, 48, and 72 h following blast exposure revealed significant time dependent effects. OHCs exposed to 150 kPa demonstrated a slow increase in cell death plateauing between 24 and 48 h, while OHCs from the high-blast group exhibited a rapid increase in cell death already at 2 h, peaking at ~24 h post-injury. Measurements of lactate dehydrogenase release into the culture medium also revealed a significant increase in cell lysis in both low- and high-blast groups compared to sham controls. OHCs were fixed at 72 h post-injury and immunostained for markers against neurons, astrocytes, and microglia. Labeling OHCs with PI, neuronal, and glial markers revealed that the blast-evoked extensive neuronal death and to a lesser extent loss of glial cells. Furthermore, our data demonstrated activation of astrocytes and microglial cells in low- and high-blasted OHCs, which reached a statistically significant difference in the high-blast group. These data confirmed that our in vitro bTBI model is a useful tool for studying cellular and molecular changes after blast exposure.
Migrants have been disproportionately impacted by COVID-19 and emerging evidence suggests they may face barriers to COVID-19 vaccination. Participatory approaches and engagement strategies are urgently needed to strengthen uptake, alongside innovative delivery mechanisms and sharing of best practice, to ensure migrants are better consider within countries' existing vaccine priority structures.
Introduction: Early evidence confirms lower COVID-19 vaccine uptake in established ethnic minority populations, yet there has been little focus on understanding vaccine hesitancy and barriers to vaccination in migrants. Growing populations of precarious migrants (including undocumented migrants, asylum seekers and refugees) in the UK and Europe are considered to be under-immunised groups and may be excluded from health systems, yet little is known about their views on COVID-19 vaccines specifically, which are essential to identify key solutions and action points to strengthen vaccine roll-out. Methods: We did an in-depth semi-structured qualitative interview study of recently arrived migrants (foreign-born, >18 years old; <10 years in the UK) to the UK with precarious immigration status between September 2020 and March 2021, seeking their input into strategies to strengthen COVID-19 vaccine delivery and uptake. We used the 'Three Cs' model (confidence, complacency and convenience) to explore COVID-19 vaccine hesitancy, barriers and access. Data were analysed using a thematic framework approach. Data collection continued until data saturation was reached, and no novel concepts were arising. The study was approved by the University of London ethics committee (REC 2020.00630). Results: We approached 20 migrant support groups nationwide, recruiting 32 migrants (mean age 37.1 years; 21 [66%] female; mean time in the UK 5.6 years [SD 3.7 years]), including refugees (n = 3), asylum seekers (n = 19), undocumented migrants (n = 8) and migrants with limited leave to remain (n = 2) from 15 different countries (5 WHO regions). 23 (72%) of 32 migrants reported being hesitant about accepting a COVID-19 vaccine and two (6%) would definitely not accept a vaccine. Participants communicated concerns over vaccine content, side-effects, lack of accessible information in an appropriate language, lack of trust in the health system and low perceived need. A range of barriers to accessing the COVID-19 vaccine were reported and concerns expressed that their communities would be excluded from or de-prioritised in the roll-out. Undocumented migrants described fears over being charged and facing immigration checks if they present for a vaccine. Participants (n = 10) interviewed after recent government announcements that COVID-19 vaccines can be accessed without facing immigration checks remained unaware of this. Participants stated that convenience of access would be a key factor in their decision around whether to accept a vaccine and proposed alternative access points to primary care services (for example, walk-in centres in trusted places such as foodbanks, community centres and charities), alongside promoting registration with primary care for all, and working closely with communities to produce accessible information on COVID-19 vaccination. Conclusions: Precarious migrants may be hesitant about accepting a COVID-19 vaccine and face multiple and unique barriers to access, requiring simple but innovative solutions to ensure equitable access and uptake. Vaccine hesitancy and low awareness around entitlement and relevant access points could be easily addressed with clear, accessible, and tailored information campaigns, co-produced and delivered by trusted sources within marginalised migrant communities. These findings have immediate relevance to the COVID-19 vaccination initiatives in the UK and in other European and high-income countries with diverse migrant populations. Funding: NIHR.